Loading…
AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States and Canada. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that transfers the patient's own fat cells to enhance the buttocks, breasts, hips, aging hands, or other areas. Further, the company's body contouring procedures include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. Additionally, it operates various centers. The company was founded in 2012 and is headquartered in Miami Beach, Florida.
5-year financial trends. Figures in USD millions.
Latest fiscal year: 2025
Year-by-year revenue, profitability, and cash flow (USD millions, last 10 years)
| Year | Revenue | EBITDA | Net Profit | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|
| 2025 | $152M | $1M | $-12M | $1M | -13.3% | -15.8% | 45.5% |
| 2024 | $180M | $10M | $-8M | $-3M | -10.3% | -7.9% | 89.1% |
| 2023 | $196M | $20M | $-4M | $14M | -5.0% | 16.1% | -71.1% |
| 2022 | $169M | $4M | $-15M | $12M | -20.7% | - | - |
| 2021 | - |
Income statement, balance sheet, and cash flow as reported
Consolidated Figures in USD Millions.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total Revenue | - | 168.79 | 195.92 | 180.35 | 151.82 |
| Operating Revenue | - | 168.79 | 195.92 | 180.35 | 151.82 |
| Cost Of Revenue | - | 62.78 | 73.77 | 71.15 | 61.69 |
| Gross Profit | - | 106.01 | 122.14 | 109.20 | 90.13 |
| Operating Expense | - | 109.48 | 112.63 | 110.77 | 94.96 |
| Selling General And Administration | - | 101.42 | 102.38 | 98.88 | 82.18 |
| Total Expenses | - | 172.26 | 186.41 | 181.92 | 156.65 |
| Operating Income | - | -3.47 | 9.51 | -1.57 | -4.83 |
| Total Operating Income As Reported | - | -4.54 | 9.72 | -1.58 | -11.56 |
| EBITDA | - | 3.52 | 19.98 | 10.30 | 1.22 |
| Normalized EBITDA | - | 4.60 | 19.76 | 10.32 | 7.95 |
| EBIT | - | -4.54 | 9.72 | -1.58 | -11.56 |
| Interest Expense | - | 6.75 | 6.48 | 6.25 | 6.08 |
| Net Interest Income | - | -6.75 | -6.48 | -6.25 | -6.08 |
| Other Income Expense | - | -1.08 | 0.21 | -0.02 | -6.73 |
| Interest Expense Non Operating | - | 6.75 | 6.48 | 6.25 | 6.08 |
| Net Non Operating Interest Income Expense | - | -6.75 | -6.48 | -6.25 | -6.08 |
| Pretax Income | - | -11.30 | 3.24 | -7.83 | -17.64 |
| Tax Provision | - | 3.38 | 7.48 | 0.19 | -5.97 |
| Tax Rate For Calcs | - | 0 | 0 | 0 | 0 |
| Tax Effect Of Unusual Items | - | -0.23 | 0.04 | 0 | -2.27 |
| Net Income Continuous Operations | - | -14.68 | -4.24 | -8.02 | -11.67 |
| Net Income From Continuing And Discontinued Operation | - | -14.68 | -4.24 | -8.02 | -11.67 |
| Net Income From Continuing Operation Net Minority Interest | - | -14.68 | -4.24 | -8.02 | -11.67 |
| Net Income | - | -14.68 | -4.24 | -8.02 | -11.67 |
| Net Income Common Stockholders | - | -14.68 | -4.24 | -8.02 | -11.67 |
| Net Income Including Noncontrolling Interests | - | -14.68 | -4.24 | -8.02 | -11.67 |
| Normalized Income | - | -13.83 | -4.41 | -8.01 | -7.21 |
| Diluted NI Availto Com Stockholders | - | -14.68 | -4.24 | -8.02 | -11.67 |
| Basic Average Shares | - | 55.68 | 56.78 | 57.69 | 60.45 |
| Diluted Average Shares | - | 55.68 | 56.78 | 57.69 | 60.45 |
| Reconciled Depreciation | - | 8.06 | 10.25 | 11.89 | 12.78 |
| Reconciled Cost Of Revenue | - | 62.78 | 73.77 | 71.15 | 61.69 |
| Total Unusual Items | - | -1.08 | 0.21 | -0.02 | -6.73 |
| Total Unusual Items Excluding Goodwill | - | -1.08 | 0.21 | -0.02 | -6.73 |
| Special Income Charges | - | -1.08 | 0.21 | -0.02 | -6.73 |
| Gain On Sale Of Business | - | - | - | - | -2.15 |
| Other Special Charges | 0.68 | 0.93 | - | - | - |
| Impairment Of Capital Assets | - | 0.15 | -0.21 | 0.02 | 4.58 |
| Depreciation Amortization Depletion Income Statement | - | 8.06 | 10.25 | 11.89 | 12.78 |
| Depreciation And Amortization In Income Statement | - | 8.06 | 10.25 | 11.89 | 12.78 |
| Gain On Sale Of Ppe | 0 | -0.15 | 0.21 | -0.02 | - |
| Otherunder Preferred Stock Dividend | 10.94 | 0 | 0 | - | - |
Healthcare sector peers, ranked by market cap
| Company | Ticker | Market Cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|---|
| AirSculpt Technologies, Inc.this co. | AIRS | $403M | -34.53 | 4.59 | -13.3% | 391.43 |
| Orthofix Medical Inc. | OFIX | $418M | -4.53 | 0.93 | -20.5% | 51.78 |
| Cross Country Healthcare, Inc. | CCRN | $409M | -4.31 | 1.27 | -29.4% | -4.69 |
| Upstream Bio, Inc. | UPB | $404M | -2.82 | 1.19 | -42.2% | -1.90 |
| Monopar Therapeutics Inc. | MNPR |
| - |
| - |
| - |
| - |
| - |
| - |
| $399M |
| -29.11 |
| 2.90 |
| -10.0% |
| -20.21 |
| Community Health Systems, Inc. | CYH | $393M | 0.77 | -0.28 | -36.5% | 5.53 |
| TruBridge, Inc. | TBRG | $391M | 89.74 | 2.20 | 2.4% | 12.54 |
| OmniAb, Inc. | OABI | $386M | -5.95 | 1.44 | -24.3% | -8.06 |
| Compass Therapeutics, Inc. | CMPX | $384M | -5.77 | 1.95 | -33.8% | -5.08 |
| Peer Median | - | -4.42 | 1.36 | -26.8% | -3.29 | |